Search Within

Steven Maron

  1. "Human Oncology and Pathogenesis Program"
Formats
  1. Meeting Abstract (21)
  2. Journal Article (16)
  3. Conference Paper (1)
Groups
  1. Department of Medicine (38)
  2. GSK Faculty (38)
  3. Gastrointestinal Oncology Service (38)
  4. Human Oncology and Pathogenesis Program (38)
  5. Solid Tumor Oncology Division (38)
  6. Epidemiology and Biostatistics (34)

More Groups

People
  1. Nikolaus Schultz (29)
  2. Yelena Janjigian (28)
  3. Geoffrey Ku (23)
  4. David Ilson (18)
  5. David Solit (15)
  6. Laura Tang (15)

More People

Years
  1. 2025 (2)
  2. 2024 (6)
  3. 2023 (11)
  4. 2022 (8)
  5. 2021 (6)
  6. 2020 (3)

More Years

Publications
  1. Journal of Clinical Oncology (14)
  2. Clinical Cancer Research (4)
  3. Annals of Oncology (3)
  4. Annals of Surgery (2)
  5. Cancer Research (2)
  6. JAMA Network Open (2)

More Publications

Publishers
  1. American Society of Clinical Oncology (16)
  2. American Association for Cancer Research (6)
  3. Oxford University Press (4)
  4. American Medical Association (2)
  5. Elsevier Inc. (2)
  6. Elsevier Science, Inc. (2)

More Publishers

Results (38)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Local therapy for oligoprogression or consolidation in high mutational burden stage 4 colorectal cancer treated with PD-1 or PD-L1 blockade
    Journal Article

    Klemen, N. D.; Court, C. M.; Fernandes, M. C.; Walch, H. S.; Chatila, W. K.; Saadat, L. V.; Maron, S.; Crane, C.; Shia, J.; Cercek, A.; more...
    Annals of Surgical Oncology (2022)

    Fulltext@MSK | Save
  • A novel microbiome signature in gastric cancer: A two independent cohort retrospective analysis
    Conference Paper

    Abate, M.; Vos, E.; Gonen, M.; Janjigian, Y. Y.; Schattner, M.; Laszkowska, M.; Tang, L.; Maron, S. B.; Coit, D. G.; Vardhana, S.; more...
    Lippincott Williams & Wilkins (2022)

    Fulltext@MSK | Save
  • Outcomes and molecular features of brain metastasis in gastroesophageal adenocarcinoma
    Journal Article

    Tsai, C.; Nguyen, B.; Luthra, A.; Chou, J. F.; Feder, L.; Tang, L. H.; Strong, V. E.; Molena, D.; Jones, D. R.; Coit, D. G.; more...
    JAMA Network Open (2022)

    Fulltext@MSK | Save
  • The role of the TP53 pathway in predicting response to neoadjuvant therapy in esophageal adenocarcinoma
    Journal Article

    Sihag, S.; Nussenzweig, S. C.; Walch, H. S.; Hsu, M.; Tan, K. S.; De La Torre, S.; Janjigian, Y. Y.; Maron, S. B.; Ku, G. Y.; Tang, L. H.; more...
    Clinical Cancer Research (2022)

    Fulltext@MSK | Save
  • Brain metastasis in gastroesophageal adenocarcinoma: Outcomes and molecular features
    Meeting Abstract

    Tsai, C.; Nguyen, B.; Luthra, A.; Chou, J. F.; Tang, L. H.; Strong, V. E.; Molena, D.; Jones, D. R.; Coit, D. G.; Ilson, D. H.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Distinct differences in genomic profile of gastric and gastroesophageal junction adenocarcinoma
    Meeting Abstract

    Nakauchi, M.; Walch, H. S.; Chatila, W. K.; Tran, T.; Vos, E. L.; Sihag, S.; Tang, L. H.; Coit, D. G.; Stadler, Z. K.; Janjigian, Y. Y.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Defining and targeting esophagogastric cancer genomic subsets with patient-derived xenografts
    Journal Article

    Moy, R. H.; Walch, H. S.; Mattar, M.; Chatila, W. K.; Molena, D.; Strong, V. E.; Tang, L. H.; Maron, S. B.; Coit, D. G.; Jones, D. R.; more...
    JCO Precision Oncology (2022)

    Fulltext@MSK | Save
  • Early predictors of benefit to dual anti-PD1/HER2 inhibition: Biomarker analysis from phase 2 trial of pembrolizumab/trastuzumab in HER2-positive metastatic esophagogastric (mEG) cancer
    Meeting Abstract

    Maron, S. B.; Chatila, W. K.; Walch, H. S.; Ptashkin, R.; Sabwa, S.; Ling, L.; Nagy, R.; Simmons, M.; Do, R. K. G.; Paroder, V.; more...
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save
  • Frequency of minimal residual disease as measured by ctDNA in mismatch repair deficient tumors following curative resection
    Meeting Abstract

    Lumish, M. A.; Jayakumaran, G.; Fox, M.; Sabwa, S.; Cercek, A.; Stadler, Z. K.; Ku, G. Y.; Segal, N. H.; Won, E.; Maron, S. B.; more...
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save
  • Frequency of minimal residual disease as measured by ctDNA in mismatch repair deficient tumors following curative resection
    Meeting Abstract

    Janjigian, Y.; Lumish, M.; Jayakumaran, G.; Fox, M.; Sabwa, S.; Cercek, A.; Stadler, Z.; Ku, G.; Segal, N.; Won, E.; more...
    Annals of Oncology (2021)

    Fulltext@MSK | Save